Literature DB >> 26026973

Deciphering discord: How Drosophila research has enhanced our understanding of the importance of FMRP in different spatial and temporal contexts.

Eliana D Weisz1, Rachel E Monyak1, Thomas A Jongens2.   

Abstract

Fragile X Syndrome (FXS) is the most common heritable form of intellectual impairment as well as the leading monogenetic cause of autism. In addition to its canonical definition as a neurodevelopmental disease, recent findings in the clinic suggest that FXS is a systemic disorder that is characterized by a variety of heterogeneous phenotypes. Efforts to study FXS pathogenesis have been aided by the development and characterization of animal models of the disease. Research efforts in Drosophila melanogaster have revealed key insights into the mechanistic underpinnings of FXS. While much remains unknown, it is increasingly apparent that FXS involves a myriad of spatially and temporally specific alterations in cellular function. Consequently, the literature is filled with numerous discordant findings. Researchers and clinicians alike must be cognizant of this dissonance, as it will likely be important for the design of preclinical studies to assess the efficacy of therapeutic strategies to improve the lives of FXS patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circadian behavior; Drosophila; Fragile X; Memory; Neurogenesis

Mesh:

Substances:

Year:  2015        PMID: 26026973     DOI: 10.1016/j.expneurol.2015.05.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

Review 1.  Multifarious Functions of the Fragile X Mental Retardation Protein.

Authors:  Jenna K Davis; Kendal Broadie
Journal:  Trends Genet       Date:  2017-08-18       Impact factor: 11.639

2.  Neuron class-specific requirements for Fragile X Mental Retardation Protein in critical period development of calcium signaling in learning and memory circuitry.

Authors:  Caleb A Doll; Kendal Broadie
Journal:  Neurobiol Dis       Date:  2016-02-03       Impact factor: 5.996

3.  Metformin as targeted treatment in fragile X syndrome.

Authors:  A B C Dy; F Tassone; M Eldeeb; M J Salcedo-Arellano; N Tartaglia; R Hagerman
Journal:  Clin Genet       Date:  2017-09-25       Impact factor: 4.438

4.  The conserved alternative splicing factor caper regulates neuromuscular phenotypes during development and aging.

Authors:  M Brandon Titus; Ethan G Wright; Jeremy M Bono; Andrea K Poliakon; Brandon R Goldstein; Meg K Super; Lauren A Young; Melpomeni Manaj; Morgan Litchford; Noreen E Reist; Darrell J Killian; Eugenia C Olesnicky
Journal:  Dev Biol       Date:  2021-01-27       Impact factor: 3.582

Review 5.  Fragile X syndrome and fragile X-associated disorders.

Authors:  Akash Rajaratnam; Jasdeep Shergill; Maria Salcedo-Arellano; Wilmar Saldarriaga; Xianlai Duan; Randi Hagerman
Journal:  F1000Res       Date:  2017-12-08

Review 6.  Drosophila as a Model for Assessing the Function of RNA-Binding Proteins during Neurogenesis and Neurological Disease.

Authors:  Eugenia C Olesnicky; Ethan G Wright
Journal:  J Dev Biol       Date:  2018-08-18

Review 7.  Modeling Fragile X Syndrome in Drosophila.

Authors:  Małgorzata Drozd; Barbara Bardoni; Maria Capovilla
Journal:  Front Mol Neurosci       Date:  2018-04-16       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.